Copyright
©The Author(s) 2004.
World J Gastroenterol. Oct 1, 2004; 10(19): 2791-2794
Published online Oct 1, 2004. doi: 10.3748/wjg.v10.i19.2791
Published online Oct 1, 2004. doi: 10.3748/wjg.v10.i19.2791
Table 1 Clinical and pathological characteristics in control and adjuvant TACE groups patients without risk factors for residual tumor
Characteristics | Control | Adjuvant TACE | P value |
(n = 174) | group (n = 77) | ||
Gender | |||
Female | 34 | 5 | 0.009 |
Male | 140 | 72 | |
Age (mean ± SD) | 50.86 ± 11.61 | 49.35 ± 10.04 | 0.323 |
HBsAg | |||
Positive | 43 | 11 | 0.135 |
Negative | 131 | 66 | |
Cirrhosis | |||
Absent | 22 | 6 | 0.130 |
Mild | 53 | 33 | |
Severe | 99 | 38 | |
Child-pugh Class | |||
A | 165 | 77 | 0.134 |
B | 5 | 0 | |
AFP (mean ± SD, ug/L) | 333.91 ± 529.92 | 406.04 ± 735.16 | 0.381 |
TNM classification | |||
I | 28 | 19 | 0.108 |
II | 146 | 58 |
Table 2 Clinical and pathological characteristics in control and adjuvant TACE groups patients with risk factors for re-sidual tumor
Characteristics | Control | Adjuvant TACE group | P value |
(n = 190) | (n = 108) | ||
Gender | |||
Female | 33 | 12 | 0.147 |
Male | 157 | 96 | |
Age (mean ± SD) | 51.50 ± 11.72 | 49.63 ± 10.07 | 0.105 |
HBsAg | |||
Positive | 47 | 27 | 0.588 |
Negative | 143 | 81 | |
Cirrhosis | |||
Absent | 41 | 24 | 0.563 |
Mild | 69 | 45 | |
Severe | 80 | 39 | |
Child-pugh Class | |||
A | 187 | 106 | 0.860 |
B | 3 | 2 | |
AFP (mean ± SD, μg/L) | 501.39 ± 807.14 | 518.25 ± 707.99 | 0.856 |
TNM classification | |||
II | 113 | 66 | 0.926 |
IIIA | 55 | 31 | |
IVA | 22 | 11 |
Table 3 Multivariate Cox proportional hazard analysis to evaluate independent variables in patients without risk fac-tors for residual tumor
Variables | B | Wald | Significance | HR | 95%CI lower upper | |
Cirrhosis | 0.689 | 14.443 | 0.000 | 1.991 | 1.396 | 2.841 |
Absent = 1 | ||||||
Mild = 2 | ||||||
Severe = 3 | ||||||
Tumor | 0.235 | 6.019 | 0.014 | 1.264 | 1.048 | 1.525 |
diameter (cm) |
Table 4 Multivariate Cox proportional hazard analysis to evaluate independent variables in patients with risk factors for residual tumor
Variables | B | Wald | Significance | HR | 95% lower upper | |
AFP (μg/L) | 0.212 | 5.333 | 0.021 | 1.236 | 1.033 | 1.480 |
< 20 = 1 | ||||||
21-400 = 2 | ||||||
> 400 = 3 | ||||||
Adjuvant TACE | -0.406 | 6.041 | 0.014 | 0.666 | 0.482 | 0.921 |
Without = 1 | ||||||
With = 2 | ||||||
Tumor diameter (cm) | 0.076 | 16.327 | 0.000 | 1.079 | 1.040 | 1.119 |
Vascular invasion | 0.245 | 7.691 | 0.006 | 1.278 | 1.075 | 1.520 |
Absent = 1 | ||||||
Present = 2 |
- Citation: Ren ZG, Lin ZY, Xia JL, Ye SL, Ma ZC, Ye QH, Qin LX, Wu ZQ, Fan J, Tang ZY. Postoperative adjuvant arterial chemoembolization improves survival of hepatocellular carcinoma patients with risk factors for residual tumor: A retrospective control study. World J Gastroenterol 2004; 10(19): 2791-2794
- URL: https://www.wjgnet.com/1007-9327/full/v10/i19/2791.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i19.2791